Joe Fiandra Access to Home Infusion Act of 2025

This bill expands Medicare coverage for home infusion therapy by changing how external infusion pumps and certain non-self-administered drugs are treated as durable medical equipment. It requires that these items be covered if three conditions are met: the drug's FDA-approved instructions require professional supervision, a qualified home infusion supplier administers/supervises the therapy at home, and the drug requires at least 12 infusions annually (either IV/subcutaneous or at pump-requiring rates). The bill directly affects Medicare beneficiaries needing long-term infusion drugs and qualified home infusion therapy suppliers. It also mandates that Medicare notify patients about cost-sharing differences between home infusion therapy and other care settings. This policy change clarifies coverage for specific home-based infusion treatments under defined safety and frequency requirements.